Literature DB >> 23886893

Neurodevelopment after fetal growth restriction.

Ahmet A Baschat1.   

Abstract

Fetal growth restriction (FGR) can emerge as a complication of placental dysfunction and increases the risk for neurodevelopmental delay. Marked elevations of umbilical artery (UA) Doppler resistance that set the stage for cardiovascular and biophysical deterioration with subsequent preterm birth characterize early-onset FGR. Minimal, or absent UA Doppler abnormalities and isolated cerebral Doppler changes with subtle deterioration and a high risk for unanticipated term stillbirth are characteristic for late-onset FGR. Nutritional deficiency manifested in lagging head growth is the most powerful predictor of developmental delay in all forms of FGR. Extremes of blood flow resistance and cardiovascular deterioration, prematurity and intracranial hemorrhage increase the risks for psychomotor delay and cerebral palsy. In late-onset FGR, regional cerebral vascular redistribution correlates with abnormal behavioral domains. Irrespective of the phenotype of FGR, prenatal tests that provide precise and independent stratification of risks for adverse neurodevelopment have yet to be determined.

Entities:  

Mesh:

Year:  2013        PMID: 23886893     DOI: 10.1159/000353631

Source DB:  PubMed          Journal:  Fetal Diagn Ther        ISSN: 1015-3837            Impact factor:   2.587


  36 in total

1.  Impaired fetoplacental angiogenesis in growth-restricted fetuses with abnormal umbilical artery doppler velocimetry is mediated by aryl hydrocarbon receptor nuclear translocator (ARNT).

Authors:  Emily J Su; Hong Xin; Ping Yin; Matthew Dyson; John Coon; Kathryn N Farrow; Karen K Mestan; Linda M Ernst
Journal:  J Clin Endocrinol Metab       Date:  2015-01       Impact factor: 5.958

2.  Overexpression of the aryl hydrocarbon receptor nuclear translocator partially rescues fetoplacental angiogenesis in severe fetal growth restriction.

Authors:  Shuhan Ji; Hong Xin; Emily J Su
Journal:  Clin Sci (Lond)       Date:  2019-06-20       Impact factor: 6.124

Review 3.  Clinician performed ultrasound in fetal growth restriction: fetal, neonatal and pediatric aspects.

Authors:  A Sehgal; F Crispi; M R Skilton; W-P de Boode
Journal:  J Perinatol       Date:  2017-08-24       Impact factor: 2.521

4.  FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction.

Authors:  Nir Melamed; Ahmet Baschat; Yoav Yinon; Apostolos Athanasiadis; Federico Mecacci; Francesc Figueras; Vincenzo Berghella; Amala Nazareth; Muna Tahlak; H David McIntyre; Fabrício Da Silva Costa; Anne B Kihara; Eran Hadar; Fionnuala McAuliffe; Mark Hanson; Ronald C Ma; Rachel Gooden; Eyal Sheiner; Anil Kapur; Hema Divakar; Diogo Ayres-de-Campos; Liran Hiersch; Liona C Poon; John Kingdom; Roberto Romero; Moshe Hod
Journal:  Int J Gynaecol Obstet       Date:  2021-03       Impact factor: 3.561

Review 5.  Detection and assessment of brain injury in the growth-restricted fetus and neonate.

Authors:  Atul Malhotra; Michael Ditchfield; Michael C Fahey; Margie Castillo-Melendez; Beth J Allison; Graeme R Polglase; Euan M Wallace; Ryan Hodges; Graham Jenkin; Suzanne L Miller
Journal:  Pediatr Res       Date:  2017-05-17       Impact factor: 3.756

Review 6.  Electroencephalographic studies in growth-restricted and small-for-gestational-age neonates.

Authors:  Nathan J Stevenson; Melissa M Lai; Hava E Starkman; Paul B Colditz; Julie A Wixey
Journal:  Pediatr Res       Date:  2022-02-23       Impact factor: 3.756

Review 7.  Obstetric management, tests, and technologies that impact childhood development.

Authors:  Christopher M Novak; Ernest M Graham
Journal:  Dev Med Child Neurol       Date:  2019-01-28       Impact factor: 5.449

Review 8.  The consequences of fetal growth restriction on brain structure and neurodevelopmental outcome.

Authors:  Suzanne L Miller; Petra S Huppi; Carina Mallard
Journal:  J Physiol       Date:  2016-01-05       Impact factor: 5.182

9.  Support during pregnancy for women at increased risk of low birthweight babies.

Authors:  Christine E East; Mary A Biro; Suzanne Fredericks; Rosalind Lau
Journal:  Cochrane Database Syst Rev       Date:  2019-04-01

10.  Taurine improves the differentiation of neural stem cells in fetal rats with intrauterine growth restriction via activation of the PKA-CREB-BDNF signaling pathway.

Authors:  Qiong Fang; Jing Liu; Lang Chen; Qiaobin Chen; Jun Ke; Jiuyun Zhang; Ying Liu; Wei Fu
Journal:  Metab Brain Dis       Date:  2021-02-20       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.